一种全新的全系统方法,用多重向的营养药来治疗
Journal of drugs in dermatology : JDD
|March 5, 2024
概括
本研究探讨了压力和饮食等系统因素在 (AV) 管理中的作用. 它审查了AV补充剂,并介绍了一种用于治疗的新型营养药的临床试验.
科学领域:
- 皮肤病学 皮肤病学
- 营养保健品 营养保健品
- 系统性炎症 系统性炎症
背景情况:
- (AV) 疗法传统上针对的是pilosebaceous单元机制.
- 新出现的证据表明,压力,饮食和微生物群等系统因素会影响AV.
- 解决这些系统性驱动因素为管理提供了新的治疗途径.
研究的目的:
- 审查针对的系统性驱动因素的补充剂的证据.
- 提出一项临床研究,评估用于AV治疗的多成分营养药.
- 评估针对的新型营养药物干预措施的安全性和有效性.
主要方法:
- 对补充剂的系统性审查 的系统性驱动者.
- 临床试验评估一种营养药物组合用于管理.
- 对人类试验对象的安全性和有效性终点的评估.
主要成果:
- 有证据表明,维生素,矿物质和植物可以减轻与系统驱动因素相关的炎症.
- 临床研究表明,测试的营养药物在治疗AV的安全性和有效性.
- 这种营养药物在通过多方面的方法来解决的治疗方面表现有前途.
结论:
- 系统性因素在的发展和恶化中起着重要作用.
- 针对这些全身驱动因素的营养药物代表了对AV的有希望的治疗策略.
- 对基于证据的补充剂的进一步研究可以增强的治疗方案.
相关概念视频
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
Nursing Clinical Information System
777
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
777
Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Drug Administration and Therapy Phases: Overview
462
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
462


